Every Hayes publication is developed by multidisciplinary teams of clinicians and scientists using rigorous methods grounded in internally recognized standards for systematic review and Health Technology Assessment. Learn more about these evidence resources and see sample titles below.
See below for some of our recent publications.
Focus of the Report: The focus of this Health Technology Assessment is to evaluate the safety and effectiveness of systemic hyperbaric oxygen therapy (HBOT) to treat adults with persistent post-concussive syndrome (PCS) after mild traumatic brain injury (mTBI).
Technology Description:…
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of masculinizing voice and communication therapy for improvement in quality of life (QOL) or patient-reported measures of voice satisfaction or comfort, vocal skills, or voice masculinity for individuals with gender dysphoria (…
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the eCoin Peripheral Neurostimulator System in patients with urgency urinary incontinence (UUI).
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of feminizing voice and communication therapy for improvement in quality of life (QOL) or patient-reported measures of voice satisfaction or comfort, vocal skills, or voice femininity for individuals with gender dysphoria (GD)….
Focus of the Report: The focus of this Health Technology Assessment (HTA) is to evaluate the safety and effectiveness of cyanoacrylate embolization (CAE) with the VenaSeal closure system (Medtronic Inc.) to treat symptomatic varicose veins. This HTA also compares the effectiveness and safety of the VenaSeal closure system with other endovenou…
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the hybrid autologous chondrocyte implantation (ACI)/osteochondral autograft transfer system (OATS) procedure for treatment of osteochondral defects of the knee in adults. This report does not evaluate ACI or OATS as standal…
This report evaluates the analytical validity, clinical validity, and clinical utility of the PancraGEN (Interpace Diagnostics) test.
This report evaluates the analytical validity, clinical validity, and clinical utility of the PancraGEN (Interpace Diagnostics) test.
Focus of the Report: The focus of this Health Technology Assessment (HTA) is to evaluate the effectiveness and safety of magnetic sphincter augmentation (MSA) with the LINX Reflux Management System (Torax Medical Inc., acquired by Ethicon Inc.) for the treatment of gastroesophageal reflux disease (GERD).
Betibeglogene autotemcel (beti-cel; Zynteglo; formerly Lentiviral Autologous Beta-Globin Gene Therapy, LentiGlobin) is an autologous hematopoietic stem cell-based gene therapy for the treatment of adult and pediatric patients with β-thalassemia who require regular red blood cell (RBC) transfusions.Betibeglogene Autotemcel (Zynteglo) for Beta Thalassemia